These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36312907)

  • 1. Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic.
    Valizadeh J; Boloukifar S; Soltani S; Jabalbarezi Hookerd E; Fouladi F; Andreevna Rushchtc A; Du B; Shen J
    Expert Syst Appl; 2023 Mar; 214():119009. PubMed ID: 36312907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated blockchain-enabled multi-channel vaccine supply chain network under hybrid uncertainties.
    Shiri M; Fattahi P; Sogandi F
    Sci Rep; 2024 Oct; 14(1):22829. PubMed ID: 39353990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.
    Kamran MA; Kia R; Goodarzian F; Ghasemi P
    Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing a sustainable reverse supply chain network for COVID-19 vaccine waste under uncertainty.
    Amani Bani E; Fallahi A; Varmazyar M; Fathi M
    Comput Ind Eng; 2022 Dec; 174():108808. PubMed ID: 36405560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.
    Shiri M; Ahmadizar F
    J Ambient Intell Humaniz Comput; 2022 Jun; ():1-25. PubMed ID: 35692508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimization framework for COVID-19 vaccine allocation and inventory management: A case study.
    Nahofti Kohneh J; Amirdadi M; Teimoury E
    Appl Soft Comput; 2023 Jan; 132():109801. PubMed ID: 36407088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust optimization problem for drone-based equitable pandemic vaccine distribution with uncertain supply.
    Wang X; Jiang R; Qi M
    Omega; 2023 Sep; 119():102872. PubMed ID: 37020741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain.
    Gilani H; Sahebi H
    Omega; 2022 Jul; 110():102637. PubMed ID: 35291647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bi-objective optimization of a stochastic resilient vaccine distribution network in the context of the COVID-19 pandemic.
    Mohammadi M; Dehghan M; Pirayesh A; Dolgui A
    Omega; 2022 Dec; 113():102725. PubMed ID: 35915776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust optimization model of anti-epidemic supply chain under technological innovation: learning from COVID-19.
    Song M; Yuan S; Bo H; Song J; Pan X; Jin K
    Ann Oper Res; 2022 Jul; ():1-31. PubMed ID: 35855699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green Closed-Loop Supply Chain Network Design During the Coronavirus (COVID-19) Pandemic: a Case Study in the Iranian Automotive Industry.
    Abbasi S; Daneshmand-Mehr M; Ghane Kanafi A
    Environ Model Assess (Dordr); 2023; 28(1):69-103. PubMed ID: 36540109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood plasma supply chain planning to respond COVID-19 pandemic: a case study.
    Fallahi A; Mousavian Anaraki SA; Mokhtari H; Niaki STA
    Environ Dev Sustain; 2022 Dec; ():1-52. PubMed ID: 36530360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine distribution planning using a congested queuing system-A real case from Australia.
    Jahani H; Chaleshtori AE; Khaksar SMS; Aghaie A; Sheu JB
    Transp Res E Logist Transp Rev; 2022 Jul; 163():102749. PubMed ID: 35664528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal planning of the COVID-19 vaccine supply chain.
    Georgiadis GP; Georgiadis MC
    Vaccine; 2021 Aug; 39(37):5302-5312. PubMed ID: 34373118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A socio-economic optimization model for blood supply chain network design during the COVID-19 pandemic: An interactive possibilistic programming approach for a real case study.
    Tirkolaee EB; Golpîra H; Javanmardan A; Maihami R
    Socioecon Plann Sci; 2023 Feb; 85():101439. PubMed ID: 36164508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling a sustainable vaccine supply chain for a healthcare system.
    Chowdhury NR; Ahmed M; Mahmud P; Paul SK; Liza SA
    J Clean Prod; 2022 Oct; 370():133423. PubMed ID: 35975192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possibilistic-robust-fuzzy programming model for designing a game theory based blood supply chain network.
    Ghasemi P; Goodarzian F; Abraham A; Khanchehzarrin S
    Appl Math Model; 2022 Dec; 112():282-303. PubMed ID: 35946032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A data-driven optimization model to response to COVID-19 pandemic: a case study.
    Eshkiti A; Sabouhi F; Bozorgi-Amiri A
    Ann Oper Res; 2023 Jun; ():1-50. PubMed ID: 37361061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.
    Hessel L;
    Influenza Other Respir Viruses; 2009 Jul; 3(4):165-70. PubMed ID: 19627373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social equity-based distribution networks design for the COVID-19 vaccine.
    Dastgoshade S; Shafiee M; Klibi W; Shishebori D
    Int J Prod Econ; 2022 Aug; 250():108684. PubMed ID: 36337682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.